Structure–Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094886 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tiara Padayachee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Microbiology, Faculty of Science, Agriculture and Engineering, University of Zululand, Empangeni 3886, South Africa. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zululand, South Africa, National Research Foundation (NRF), South Africa, University of Zululan.
Abstract (Originalsprache)
Cytochrome P450 CYP121A1 is a well-known drug target against Mycobacterium tuberculosis, the human pathogen that causes the deadly disease tuberculosis (TB). CYP121A1 is a unique P450 enzyme because it uses classical and non-classical P450 catalytic processes and has distinct structural features among P450s. However, a detailed investigation of CYP121A1 protein structures in terms of active site cavity dynamics and key amino acids interacting with bound ligands has yet to be undertaken. To address this research knowledge gap, 53 CYP121A1 crystal structures were investigated in this study. Critical amino acids required for CYP121A1’s overall activity were identified and highlighted this enzyme’s rigid architecture and substrate selectivity. The CYP121A1-fluconazole crystal structure revealed a novel azole drug–P450 binding mode in which azole heme coordination was facilitated by a water molecule. Fragment-based inhibitor approaches revealed that CYP121A1 can be inhibited by molecules that block the substrate channel or by directly interacting with the P450 heme. This study serves as a reference for the precise understanding of CYP121A1 interactions with different ligands and the structure–function analysis of P450 enzymes in general. Our findings provide critical information for the synthesis of more specific CYP121A1 inhibitors and their development as novel anti-TB drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Microbiology, Faculty of Science, Agriculture and Engineering, University of Zululand, Empangeni 3886, South Africa.
- Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.
- Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
ORCID-Profile: Tiara Padayachee, David R Nelson, Khajamohiddin Syed
Förderung
- University of Zululand, South Africa
- National Research Foundation (NRF), South Africa
- University of Zululan
Zitieren
APA
Padayachee, T., Lamb, D. C., Nelson, D. R., & Syed, K. (2024). Structure–Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094886
Vancouver
Padayachee T, Lamb DC, Nelson DR, Syed K. Structure–Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094886
BibTeX
@article{Padayachee2024,
author = {Padayachee, Tiara and Lamb, David C and Nelson, David R and Syed, Khajamohiddin},
title = {Structure–Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094886}
}
EUVIMED